Login / Signup

Strategies to Guide Preemptive Waitlisting and Equity in Wait Time Accrual by Race/Ethnicity.

Elaine KuTimothy P CopelandLing ChenMatthew R WeirCharles E McCullochKirsten L JohansenNaeem GoussousJonathan D SavantIsabelle LopezSandra Amaral
Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)
Use of a risk-based strategy was associated with greater racial equity in waittime accrual compared with use of a standard single eGFR threshold to determine eligibility for preemptive waitlisting.
Keyphrases
  • small cell lung cancer
  • global health
  • epidermal growth factor receptor
  • tyrosine kinase
  • african american